ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

ACCC Annual Meeting Jan. 27-29; Upton To speak

November 4, 1977

In Brief: NCI Terminates Straus’ Grant Following Site Visit Report Charging “Lack Of satisfactory Progress

February 19, 1982

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995

Clinical Trials Approved By NCI

October 31, 2003

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001